1. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers
   Elizabeth Hull et al, 2017, IJMS CrossRef
2. Glypican 4 and Mmp14 interact in regulating the migration of anterior endodermal cells by limiting extracellular matrix deposition
   Bo Hu et al, 2018, Development CrossRef
3. An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis.
   Qi Zhang et al, 2018, Biomater Sci CrossRef
4. Study on Diagnostic Values of Astrocyte Elevated Gene 1 (AEG-1) and Glypican 3 (GPC-3) in Hepatocellular Carcinoma
   Wenqing Cao et al, 2019 CrossRef
5. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.
   Pei Wang et al, 2020, Immunobiology CrossRef
6. The Expression of Glypican-3 in Colorectal Cancer
   Sonia Azizpour et al, 2019, Cytol. Genet. CrossRef
7. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells
   Gebing Yao et al, 2019, BioMed Research International CrossRef
8. Bone Marrow-Derived Mesenchymal Stem Cell Potential Regression of Dysplasia Associating Experimental Liver Fibrosis in Albino Rats
   Yasmine H. Khalifa et al, 2019, BioMed Research International CrossRef
9. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
   Kenya Kamimura et al, 2019, Cancers CrossRef
10. Engineered Anti‐GPC3 Immunotoxin, HN3‐ABD‐T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention
    Bryan D. Fleming et al, 2020, Hepatology CrossRef
11. High GLYPICAN-3 expression Characterizes a Biologically Distinct subset of ovarian clear cell carcinomas in Canadian patients: An Opportunity for targeted Therapy
    Katharina Wiedemeyer et al, 2020, Human Pathology CrossRef
12. Development of a Minimal Physiologically-Based Pharmacokinetic/ Pharmacodynamic Model to Characterize Target Cell Depletion and Cytokine Release for T Cell-Redirecting Bispecific Agents in Humans
    Xiling Jiang et al, 2020, European Journal of Pharmaceutical Sciences CrossRef
13. Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma.
    Lijie Xia et al, 2020, Int J Nanomedicine CrossRef
14. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice
    Dan Li et al, 2020, Gastroenterology CrossRef
15. Human Hepatocellular Carcinoma (HCC)
    Luigi Buonaguro, 2020, Cancers CrossRef
16. Glypican-3 electrochemical aptasensor based on reduced graphene oxide‐chitosan‐ferrocene deposition of platinum–palladium bimetallic nanoparticles
    Xiaohang Shi et al, 2021, J Appl Electrochem CrossRef
17. A novel multifunctional gold nanorod-mediated and tumor-targeted gene silencing of GPC-3 synergizes photothermal therapy for liver cancer.
    Yanling Liu et al, 2021, Nanotechnology CrossRef
18. Label-free electrochemical aptasensor based on reduced graphene oxide–hemin–chitosan nanocomposite for the determination of glypican-3
    Min Chen et al, 2021, New J. Chem. CrossRef
19. Cellular based treatment modalities for unresectable hepatocellular carcinoma
    Konstantinos Damiris et al, 2021, WJCO CrossRef
20. null
    Devaraj Ezhilarasan et al, 2021 CrossRef
21. A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
    Arutselvan Natarajan et al, 2021, Cancers CrossRef
22. Targeting acute myeloid leukemia cells by CD33 receptor-specific MoS2-based nanoconjugates
    Pavol Štefík et al, 2021, Biomed. Mater. CrossRef
23. Novel Molecular Targets for Hepatocellular Carcinoma
    Beatrice Cavalluzzo et al, 2021, Cancers CrossRef
24. null
    Dan Li et al, 2022 CrossRef
25. null
    Urvashi Vijay et al, 2022 CrossRef
26. Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells
    Yoshika Iwata et al, 2022, Toxicology and Applied Pharmacology CrossRef
27. A cell transmembrane peptide chimeric M(27–39)-HTPP targeted therapy for hepatocellular carcinoma
    Jibin Wu et al, 2023, iScience CrossRef
28. Serum Biomarkers and Ultrasensitive Biosensors for Diagnosis of Early-Stage Hepatocellular Carcinoma
    Lorico DS. Lapitan et al, 2023, Sensors and Actuators B: Chemical CrossRef
29. Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
    Montalbano Mauro et al, 2023, IJMS CrossRef
30. Profiling of single-vesicle surface proteins via droplet digital immuno-PCR for multi-subpopulation extracellular vesicles counting towards cancer diagnostics
    Chunchen Liu et al, 2023, Chemical Engineering Journal CrossRef
31. Targeted Near-Infrared Fluorescence Imaging of Liver Cancer using Dual-Peptide-Functionalized Albumin Particles
    Wei-Tao Dou et al, 2024, Chemical & Biomedical Imaging CrossRef
32. Molecular mechanisms of human overgrowth and use of omics in its diagnostics: chances and challenges
    Dirk Prawitt et al, 2024, Front. Genet. CrossRef
33. Discovery of Genomic Loci for Liver Health and Steatosis Reveals Overlap with Glutathione Redox Genetics
    Rebecca L. Koch et al, 2024, Redox Biology CrossRef
34. Construction of GPC3-modified Lipopolymer SiRNA Delivery System
    Dandan Sun et al, 2024, CPD CrossRef